Silke Neumann

3.2k total citations
46 papers, 1.9k citations indexed

About

Silke Neumann is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Silke Neumann has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Silke Neumann's work include Neutropenia and Cancer Infections (9 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (5 papers). Silke Neumann is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (5 papers). Silke Neumann collaborates with scholars based in Germany, New Zealand and United States. Silke Neumann's co-authors include Victor Sourjik, Yuhai Tu, Ganhui Lan, Georg Maschmeyer, Pablo Sartori, Olaf Penack, Marie von Lilienfeld‐Toal, Oliver A. Cornely, Martin Schmidt‐Hieber and Dieter Buchheidt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Silke Neumann

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Neumann Germany 24 556 541 469 356 232 46 1.9k
Holger Hennig Germany 28 439 0.8× 723 1.3× 284 0.6× 350 1.0× 50 0.2× 88 2.7k
Yoshihiko Nagai Canada 15 550 1.0× 311 0.6× 157 0.3× 159 0.4× 405 1.7× 19 2.7k
Li Shi China 21 620 1.1× 280 0.5× 328 0.7× 137 0.4× 131 0.6× 140 1.8k
Paola Paci Italy 33 2.8k 5.1× 479 0.9× 216 0.5× 369 1.0× 137 0.6× 106 4.0k
Mei Song China 25 1.2k 2.2× 1.9k 3.4× 1.1k 2.3× 266 0.7× 397 1.7× 76 4.1k
Lutz Lehmann Germany 29 522 0.9× 800 1.5× 310 0.7× 250 0.7× 85 0.4× 87 2.8k
Yu‐Chao Wang Taiwan 24 731 1.3× 166 0.3× 329 0.7× 110 0.3× 86 0.4× 120 1.8k
Xiaowei Zhu China 34 3.0k 5.5× 371 0.7× 221 0.5× 91 0.3× 696 3.0× 148 5.1k
Jun Murakami Japan 19 215 0.4× 338 0.6× 67 0.1× 199 0.6× 143 0.6× 93 1.5k
Andrea Hofmann Germany 26 580 1.0× 127 0.2× 107 0.2× 101 0.3× 168 0.7× 75 2.0k

Countries citing papers authored by Silke Neumann

Since Specialization
Citations

This map shows the geographic impact of Silke Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Neumann more than expected).

Fields of papers citing papers by Silke Neumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Neumann. The network helps show where Silke Neumann may publish in the future.

Co-authorship network of co-authors of Silke Neumann

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Neumann. A scholar is included among the top collaborators of Silke Neumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Neumann. Silke Neumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neumann, Silke, W. Bryan Burnette, Rachel T. Cox, et al.. (2024). Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin. Pediatric Neurology. 163. 1–3. 2 indexed citations
2.
Sharma, Amit, Rui L. Reis, Silke Neumann, et al.. (2023). Cutting-edge advances in modeling the blood–brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain. Cell & Bioscience. 13(1). 137–137. 14 indexed citations
3.
Nickel, Ann‐Christin, Philipp Westhoff, Amit Sharma, et al.. (2022). WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells. Cancers. 14(13). 3165–3165. 7 indexed citations
4.
Fraser‐Miller, Sara J., Silke Neumann, Donata Maciaczyk, et al.. (2021). Molecular monitoring of glioblastoma’s immunogenicity using a combination of Raman spectroscopy and chemometrics. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 252. 119534–119534. 11 indexed citations
6.
Neumann, Silke, Emma K. Gowing, Philip K. Ahring, et al.. (2019). The Delta-Subunit Selective GABAA Receptor Modulator, DS2, Improves Stroke Recovery via an Anti-inflammatory Mechanism. Frontiers in Neuroscience. 13. 1133–1133. 21 indexed citations
8.
Ullmann, Andrew J., Martin Schmidt‐Hieber, Hartmut Bertz, et al.. (2016). Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Annals of Hematology. 95(9). 1435–1455. 133 indexed citations
12.
Clausznitzer, Diana, Gabriele Micali, Silke Neumann, Victor Sourjik, & Robert G. Endres. (2014). Predicting Chemical Environments of Bacteria from Receptor Signaling. PLoS Computational Biology. 10(10). e1003870–e1003870. 24 indexed citations
13.
Neumann, Silke, et al.. (2014). Exponential Signaling Gain at the Receptor Level Enhances Signal-to-Noise Ratio in Bacterial Chemotaxis. PLoS ONE. 9(4). e87815–e87815. 7 indexed citations
14.
Vehreschild, Maria J. G. T., Jörg Janne Vehreschild, Kai Hübel, et al.. (2013). Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Oncology. 24(5). 1189–1202. 14 indexed citations
15.
Mousset, Sabine, Dieter Buchheidt, Werner Heinz, et al.. (2013). Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 93(1). 13–32. 121 indexed citations
16.
Neumann, Silke, Stefan W. Krause, Georg Maschmeyer, Xaver Schiel, & Marie von Lilienfeld‐Toal. (2013). Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors. Annals of Hematology. 92(4). 433–442. 76 indexed citations
17.
Kreuter, Michael, Johan Vansteenkiste, J.R. Fischer, et al.. (2012). Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study. Annals of Oncology. 24(4). 986–992. 56 indexed citations
18.
Khursigara, Cezar M., Ganhui Lan, Silke Neumann, et al.. (2011). Lateral density of receptor arrays in the membrane plane influences sensitivity of the E. coli chemotaxis response. The EMBO Journal. 30(9). 1719–1729. 34 indexed citations
19.
Vehreschild, Maria J. G. T., Oliver A. Cornely, Georg Maschmeyer, et al.. (2011). Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients. Haematologica. 96(12). 1855–1860. 20 indexed citations
20.
Neumann, Silke, Clinton H. Hansen, Ned S. Wingreen, & Victor Sourjik. (2010). Differences in signalling by directly and indirectly binding ligands in bacterial chemotaxis. The EMBO Journal. 29(20). 3484–3495. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026